 | • レポートコード：MRC2-11QY09082 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、151ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は呼吸器用治療薬のグローバル市場について調査・分析したレポートです。種類別（アドエア、シムビコート、スピリーバ、ゾレア、ベントリン、パルミコート、オルカンビ、レルベア/ブレオエリプタ、シングレア、エスブリエット）市場規模、用途別（病院、在宅介護）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別呼吸器用治療薬の競争状況、市場シェア ・世界の呼吸器用治療薬市場：種類別市場規模 2015年-2020年（アドエア、シムビコート、スピリーバ、ゾレア、ベントリン、パルミコート、オルカンビ、レルベア/ブレオエリプタ、シングレア、エスブリエット） ・世界の呼吸器用治療薬市場：種類別市場規模予測 2021年-2026年（アドエア、シムビコート、スピリーバ、ゾレア、ベントリン、パルミコート、オルカンビ、レルベア/ブレオエリプタ、シングレア、エスブリエット） ・世界の呼吸器用治療薬市場：用途別市場規模 2015年-2020年（病院、在宅介護） ・世界の呼吸器用治療薬市場：用途別市場規模予測 2021年-2026年（病院、在宅介護） ・北米の呼吸器用治療薬市場分析：米国、カナダ ・ヨーロッパの呼吸器用治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの呼吸器用治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の呼吸器用治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの呼吸器用治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Boehringer Ingelheim、AstraZeneca、Merck、Novartis、Omron、Sunovion、Air Liquide、Aradigm、Baxter、Beximco Pharmaceuticals、Compumedics、Pfizer、Draeger、Roche、Fisher & Paykel Healthcare、GE Healthcare、Genentech、Grifols、Hamilton Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drug used for respiratory disease.
Major factors contributing to the growth of the global respiratory drug market include increasing prevalence of chronic respiratory diseases such as asthma and COPD.
Market Analysis and Insights: Global Respiratory Drug Market
The global Respiratory Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Respiratory Drug Scope and Market Size
Respiratory Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Respiratory Drug market is segmented into
Advair
Symbicort turbuhaler
Spiriva
Xolair
Ventolin
Pulmicort
Orkambi
Relvar/breo ellipta
Singulair
Esbriet
Segment by Application, the Respiratory Drug market is segmented into
Hospitals
Home care
Regional and Country-level Analysis
The Respiratory Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Respiratory Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Respiratory Drug Market Share Analysis
Respiratory Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Respiratory Drug business, the date to enter into the Respiratory Drug market, Respiratory Drug product introduction, recent developments, etc.
The major vendors covered:
GSK
Boehringer Ingelheim
AstraZeneca
Merck
Novartis
Omron
Sunovion
Air Liquide
Aradigm
Baxter
Beximco Pharmaceuticals
Compumedics
Pfizer
Draeger
Roche
Fisher & Paykel Healthcare
GE Healthcare
Genentech
Grifols
Hamilton Medical
1 Study Coverage
1.1 Respiratory Drug Product Introduction
1.2 Market Segments
1.3 Key Respiratory Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Respiratory Drug Market Size Growth Rate by Type
1.4.2 Advair
1.4.3 Symbicort turbuhaler
1.4.4 Spiriva
1.4.5 Xolair
1.4.6 Ventolin
1.4.7 Pulmicort
1.4.8 Orkambi
1.4.9 Relvar/breo ellipta
1.4.10 Singulair
1.4.11 Esbriet
1.5 Market by Application
1.5.1 Global Respiratory Drug Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Home care
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Respiratory Drug Market Size, Estimates and Forecasts
2.1.1 Global Respiratory Drug Revenue 2015-2026
2.1.2 Global Respiratory Drug Sales 2015-2026
2.2 Global Respiratory Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Respiratory Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Respiratory Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Respiratory Drug Competitor Landscape by Players
3.1 Respiratory Drug Sales by Manufacturers
3.1.1 Respiratory Drug Sales by Manufacturers (2015-2020)
3.1.2 Respiratory Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Respiratory Drug Revenue by Manufacturers
3.2.1 Respiratory Drug Revenue by Manufacturers (2015-2020)
3.2.2 Respiratory Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Respiratory Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Respiratory Drug Revenue in 2019
3.2.5 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Respiratory Drug Price by Manufacturers
3.4 Respiratory Drug Manufacturing Base Distribution, Product Types
3.4.1 Respiratory Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Respiratory Drug Product Type
3.4.3 Date of International Manufacturers Enter into Respiratory Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Drug Market Size by Type (2015-2020)
4.1.1 Global Respiratory Drug Sales by Type (2015-2020)
4.1.2 Global Respiratory Drug Revenue by Type (2015-2020)
4.1.3 Respiratory Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Respiratory Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Respiratory Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Respiratory Drug Revenue Forecast by Type (2021-2026)
4.2.3 Respiratory Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Respiratory Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Drug Market Size by Application (2015-2020)
5.1.1 Global Respiratory Drug Sales by Application (2015-2020)
5.1.2 Global Respiratory Drug Revenue by Application (2015-2020)
5.1.3 Respiratory Drug Price by Application (2015-2020)
5.2 Respiratory Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Respiratory Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Respiratory Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Respiratory Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Respiratory Drug by Country
6.1.1 North America Respiratory Drug Sales by Country
6.1.2 North America Respiratory Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Respiratory Drug Market Facts & Figures by Type
6.3 North America Respiratory Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Respiratory Drug by Country
7.1.1 Europe Respiratory Drug Sales by Country
7.1.2 Europe Respiratory Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Respiratory Drug Market Facts & Figures by Type
7.3 Europe Respiratory Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Respiratory Drug by Region
8.1.1 Asia Pacific Respiratory Drug Sales by Region
8.1.2 Asia Pacific Respiratory Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Respiratory Drug Market Facts & Figures by Type
8.3 Asia Pacific Respiratory Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Respiratory Drug by Country
9.1.1 Latin America Respiratory Drug Sales by Country
9.1.2 Latin America Respiratory Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Respiratory Drug Market Facts & Figures by Type
9.3 Central & South America Respiratory Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Respiratory Drug by Country
10.1.1 Middle East and Africa Respiratory Drug Sales by Country
10.1.2 Middle East and Africa Respiratory Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Respiratory Drug Market Facts & Figures by Type
10.3 Middle East and Africa Respiratory Drug Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Respiratory Drug Products Offered
11.1.5 GSK Related Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description and Business Overview
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Respiratory Drug Products Offered
11.2.5 Boehringer Ingelheim Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Description and Business Overview
11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Respiratory Drug Products Offered
11.3.5 AstraZeneca Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Respiratory Drug Products Offered
11.4.5 Merck Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Respiratory Drug Products Offered
11.5.5 Novartis Related Developments
11.6 Omron
11.6.1 Omron Corporation Information
11.6.2 Omron Description and Business Overview
11.6.3 Omron Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Omron Respiratory Drug Products Offered
11.6.5 Omron Related Developments
11.7 Sunovion
11.7.1 Sunovion Corporation Information
11.7.2 Sunovion Description and Business Overview
11.7.3 Sunovion Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sunovion Respiratory Drug Products Offered
11.7.5 Sunovion Related Developments
11.8 Air Liquide
11.8.1 Air Liquide Corporation Information
11.8.2 Air Liquide Description and Business Overview
11.8.3 Air Liquide Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Air Liquide Respiratory Drug Products Offered
11.8.5 Air Liquide Related Developments
11.9 Aradigm
11.9.1 Aradigm Corporation Information
11.9.2 Aradigm Description and Business Overview
11.9.3 Aradigm Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aradigm Respiratory Drug Products Offered
11.9.5 Aradigm Related Developments
11.10 Baxter
11.10.1 Baxter Corporation Information
11.10.2 Baxter Description and Business Overview
11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baxter Respiratory Drug Products Offered
11.10.5 Baxter Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Respiratory Drug Products Offered
11.1.5 GSK Related Developments
11.12 Compumedics
11.12.1 Compumedics Corporation Information
11.12.2 Compumedics Description and Business Overview
11.12.3 Compumedics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Compumedics Products Offered
11.12.5 Compumedics Related Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Description and Business Overview
11.13.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pfizer Products Offered
11.13.5 Pfizer Related Developments
11.14 Draeger
11.14.1 Draeger Corporation Information
11.14.2 Draeger Description and Business Overview
11.14.3 Draeger Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Draeger Products Offered
11.14.5 Draeger Related Developments
11.15 Roche
11.15.1 Roche Corporation Information
11.15.2 Roche Description and Business Overview
11.15.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Roche Products Offered
11.15.5 Roche Related Developments
11.16 Fisher & Paykel Healthcare
11.16.1 Fisher & Paykel Healthcare Corporation Information
11.16.2 Fisher & Paykel Healthcare Description and Business Overview
11.16.3 Fisher & Paykel Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Fisher & Paykel Healthcare Products Offered
11.16.5 Fisher & Paykel Healthcare Related Developments
11.17 GE Healthcare
11.17.1 GE Healthcare Corporation Information
11.17.2 GE Healthcare Description and Business Overview
11.17.3 GE Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.17.4 GE Healthcare Products Offered
11.17.5 GE Healthcare Related Developments
11.18 Genentech
11.18.1 Genentech Corporation Information
11.18.2 Genentech Description and Business Overview
11.18.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Genentech Products Offered
11.18.5 Genentech Related Developments
11.19 Grifols
11.19.1 Grifols Corporation Information
11.19.2 Grifols Description and Business Overview
11.19.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Grifols Products Offered
11.19.5 Grifols Related Developments
11.20 Hamilton Medical
11.20.1 Hamilton Medical Corporation Information
11.20.2 Hamilton Medical Description and Business Overview
11.20.3 Hamilton Medical Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Hamilton Medical Products Offered
11.20.5 Hamilton Medical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Respiratory Drug Market Estimates and Projections by Region
12.1.1 Global Respiratory Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Respiratory Drug Revenue Forecast by Regions 2021-2026
12.2 North America Respiratory Drug Market Size Forecast (2021-2026)
12.2.1 North America: Respiratory Drug Sales Forecast (2021-2026)
12.2.2 North America: Respiratory Drug Revenue Forecast (2021-2026)
12.2.3 North America: Respiratory Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Respiratory Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Respiratory Drug Sales Forecast (2021-2026)
12.3.2 Europe: Respiratory Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Respiratory Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Respiratory Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Respiratory Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Respiratory Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Respiratory Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Respiratory Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Respiratory Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Respiratory Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Respiratory Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Respiratory Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Respiratory Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Respiratory Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Respiratory Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Respiratory Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Respiratory Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Respiratory Drug Market Segments
Table 2. Ranking of Global Top Respiratory Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Respiratory Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Advair
Table 5. Major Manufacturers of Symbicort turbuhaler
Table 6. Major Manufacturers of Spiriva
Table 7. Major Manufacturers of Xolair
Table 8. Major Manufacturers of Ventolin
Table 9. Major Manufacturers of Pulmicort
Table 10. Major Manufacturers of Orkambi
Table 11. Major Manufacturers of Relvar/breo ellipta
Table 12. Major Manufacturers of Singulair
Table 13. Major Manufacturers of Esbriet
Table 14. Global Respiratory Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 15. Global Respiratory Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 16. Global Respiratory Drug Sales by Regions 2015-2020 (K Pcs)
Table 17. Global Respiratory Drug Sales Market Share by Regions (2015-2020)
Table 18. Global Respiratory Drug Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Respiratory Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 20. Global Respiratory Drug Sales Share by Manufacturers (2015-2020)
Table 21. Global Respiratory Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Respiratory Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Drug as of 2019)
Table 23. Respiratory Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Respiratory Drug Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Respiratory Drug Price (2015-2020) (USD/Pcs)
Table 26. Respiratory Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Respiratory Drug Product Type
Table 28. Date of International Manufacturers Enter into Respiratory Drug Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 31. Global Respiratory Drug Sales Share by Type (2015-2020)
Table 32. Global Respiratory Drug Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Respiratory Drug Revenue Share by Type (2015-2020)
Table 34. Respiratory Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 35. Global Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 36. Global Respiratory Drug Sales Share by Application (2015-2020)
Table 37. North America Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 38. North America Respiratory Drug Sales Market Share by Country (2015-2020)
Table 39. North America Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 41. North America Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 42. North America Respiratory Drug Sales Market Share by Type (2015-2020)
Table 43. North America Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 44. North America Respiratory Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 46. Europe Respiratory Drug Sales Market Share by Country (2015-2020)
Table 47. Europe Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 49. Europe Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 50. Europe Respiratory Drug Sales Market Share by Type (2015-2020)
Table 51. Europe Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 52. Europe Respiratory Drug Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Respiratory Drug Sales by Region (2015-2020) (K Pcs)
Table 54. Asia Pacific Respiratory Drug Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Respiratory Drug Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Respiratory Drug Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 58. Asia Pacific Respiratory Drug Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 60. Asia Pacific Respiratory Drug Sales Market Share by Application (2015-2020)
Table 61. Latin America Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 62. Latin America Respiratory Drug Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 65. Latin America Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 66. Latin America Respiratory Drug Sales Market Share by Type (2015-2020)
Table 67. Latin America Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 68. Latin America Respiratory Drug Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Respiratory Drug Sales by Country (2015-2020) (K Pcs)
Table 70. Middle East and Africa Respiratory Drug Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Respiratory Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Respiratory Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Respiratory Drug Sales by Type (2015-2020) (K Pcs)
Table 74. Middle East and Africa Respiratory Drug Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Respiratory Drug Sales by Application (2015-2020) (K Pcs)
Table 76. Middle East and Africa Respiratory Drug Sales Market Share by Application (2015-2020)
Table 77. GSK Corporation Information
Table 78. GSK Description and Major Businesses
Table 79. GSK Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. GSK Product
Table 81. GSK Recent Development
Table 82. Boehringer Ingelheim Corporation Information
Table 83. Boehringer Ingelheim Description and Major Businesses
Table 84. Boehringer Ingelheim Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Boehringer Ingelheim Product
Table 86. Boehringer Ingelheim Recent Development
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Major Businesses
Table 89. AstraZeneca Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. AstraZeneca Product
Table 91. AstraZeneca Recent Development
Table 92. Merck Corporation Information
Table 93. Merck Description and Major Businesses
Table 94. Merck Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Merck Product
Table 96. Merck Recent Development
Table 97. Novartis Corporation Information
Table 98. Novartis Description and Major Businesses
Table 99. Novartis Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Novartis Product
Table 101. Novartis Recent Development
Table 102. Omron Corporation Information
Table 103. Omron Description and Major Businesses
Table 104. Omron Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Omron Product
Table 106. Omron Recent Development
Table 107. Sunovion Corporation Information
Table 108. Sunovion Description and Major Businesses
Table 109. Sunovion Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Sunovion Product
Table 111. Sunovion Recent Development
Table 112. Air Liquide Corporation Information
Table 113. Air Liquide Description and Major Businesses
Table 114. Air Liquide Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Air Liquide Product
Table 116. Air Liquide Recent Development
Table 117. Aradigm Corporation Information
Table 118. Aradigm Description and Major Businesses
Table 119. Aradigm Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Aradigm Product
Table 121. Aradigm Recent Development
Table 122. Baxter Corporation Information
Table 123. Baxter Description and Major Businesses
Table 124. Baxter Respiratory Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Baxter Product
Table 126. Baxter Recent Development
Table 127. Beximco Pharmaceuticals Corporation Information
Table 128. Beximco Pharmaceuticals Description and Major Businesses
Table 129. Beximco Pharmaceuticals Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Beximco Pharmaceuticals Product
Table 131. Beximco Pharmaceuticals Recent Development
Table 132. Compumedics Corporation Information
Table 133. Compumedics Description and Major Businesses
Table 134. Compumedics Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Compumedics Product
Table 136. Compumedics Recent Development
Table 137. Pfizer Corporation Information
Table 138. Pfizer Description and Major Businesses
Table 139. Pfizer Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Pfizer Product
Table 141. Pfizer Recent Development
Table 142. Draeger Corporation Information
Table 143. Draeger Description and Major Businesses
Table 144. Draeger Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Draeger Product
Table 146. Draeger Recent Development
Table 147. Roche Corporation Information
Table 148. Roche Description and Major Businesses
Table 149. Roche Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Roche Product
Table 151. Roche Recent Development
Table 152. Fisher & Paykel Healthcare Corporation Information
Table 153. Fisher & Paykel Healthcare Description and Major Businesses
Table 154. Fisher & Paykel Healthcare Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 155. Fisher & Paykel Healthcare Product
Table 156. Fisher & Paykel Healthcare Recent Development
Table 157. GE Healthcare Corporation Information
Table 158. GE Healthcare Description and Major Businesses
Table 159. GE Healthcare Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 160. GE Healthcare Product
Table 161. GE Healthcare Recent Development
Table 162. Genentech Corporation Information
Table 163. Genentech Description and Major Businesses
Table 164. Genentech Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 165. Genentech Product
Table 166. Genentech Recent Development
Table 167. Grifols Corporation Information
Table 168. Grifols Description and Major Businesses
Table 169. Grifols Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 170. Grifols Product
Table 171. Grifols Recent Development
Table 172. Hamilton Medical Corporation Information
Table 173. Hamilton Medical Description and Major Businesses
Table 174. Hamilton Medical Respiratory Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 175. Hamilton Medical Product
Table 176. Hamilton Medical Recent Development
Table 177. Global Respiratory Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 178. Global Respiratory Drug Sales Market Share Forecast by Regions (2021-2026)
Table 179. Global Respiratory Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 180. Global Respiratory Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 181. North America: Respiratory Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 182. North America: Respiratory Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Europe: Respiratory Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 184. Europe: Respiratory Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 185. Asia Pacific: Respiratory Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 186. Asia Pacific: Respiratory Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 187. Latin America: Respiratory Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 188. Latin America: Respiratory Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 189. Middle East and Africa: Respiratory Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 190. Middle East and Africa: Respiratory Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 191. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 192. Key Challenges
Table 193. Market Risks
Table 194. Main Points Interviewed from Key Respiratory Drug Players
Table 195. Respiratory Drug Customers List
Table 196. Respiratory Drug Distributors List
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Drug Product Picture
Figure 2. Global Respiratory Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Advair Product Picture
Figure 4. Symbicort turbuhaler Product Picture
Figure 5. Spiriva Product Picture
Figure 6. Xolair Product Picture
Figure 7. Ventolin Product Picture
Figure 8. Pulmicort Product Picture
Figure 9. Orkambi Product Picture
Figure 10. Relvar/breo ellipta Product Picture
Figure 11. Singulair Product Picture
Figure 12. Esbriet Product Picture
Figure 13. Global Respiratory Drug Sales Market Share by Application in 2020 & 2026
Figure 14. Hospitals
Figure 15. Home care
Figure 16. Respiratory Drug Report Years Considered
Figure 17. Global Respiratory Drug Market Size 2015-2026 (US$ Million)
Figure 18. Global Respiratory Drug Sales 2015-2026 (K Pcs)
Figure 19. Global Respiratory Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Respiratory Drug Sales Market Share by Region (2015-2020)
Figure 21. Global Respiratory Drug Sales Market Share by Region in 2019
Figure 22. Global Respiratory Drug Revenue Market Share by Region (2015-2020)
Figure 23. Global Respiratory Drug Revenue Market Share by Region in 2019
Figure 24. Global Respiratory Drug Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Respiratory Drug Revenue in 2019
Figure 26. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Respiratory Drug Sales Market Share by Type (2015-2020)
Figure 28. Global Respiratory Drug Sales Market Share by Type in 2019
Figure 29. Global Respiratory Drug Revenue Market Share by Type (2015-2020)
Figure 30. Global Respiratory Drug Revenue Market Share by Type in 2019
Figure 31. Global Respiratory Drug Market Share by Price Range (2015-2020)
Figure 32. Global Respiratory Drug Sales Market Share by Application (2015-2020)
Figure 33. Global Respiratory Drug Sales Market Share by Application in 2019
Figure 34. Global Respiratory Drug Revenue Market Share by Application (2015-2020)
Figure 35. Global Respiratory Drug Revenue Market Share by Application in 2019
Figure 36. North America Respiratory Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 37. North America Respiratory Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Respiratory Drug Sales Market Share by Country in 2019
Figure 39. North America Respiratory Drug Revenue Market Share by Country in 2019
Figure 40. U.S. Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. U.S. Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. Canada Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Respiratory Drug Market Share by Type in 2019
Figure 45. North America Respiratory Drug Market Share by Application in 2019
Figure 46. Europe Respiratory Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 47. Europe Respiratory Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Respiratory Drug Sales Market Share by Country in 2019
Figure 49. Europe Respiratory Drug Revenue Market Share by Country in 2019
Figure 50. Germany Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Germany Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. France Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. U.K. Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Italy Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Respiratory Drug Market Share by Type in 2019
Figure 61. Europe Respiratory Drug Market Share by Application in 2019
Figure 62. Asia Pacific Respiratory Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 63. Asia Pacific Respiratory Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Respiratory Drug Sales Market Share by Region in 2019
Figure 65. Asia Pacific Respiratory Drug Revenue Market Share by Region in 2019
Figure 66. China Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. China Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. South Korea Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. India Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Australia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Taiwan Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Indonesia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Thailand Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Malaysia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Philippines Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Vietnam Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Respiratory Drug Market Share by Type in 2019
Figure 89. Asia Pacific Respiratory Drug Market Share by Application in 2019
Figure 90. Latin America Respiratory Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Respiratory Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Respiratory Drug Sales Market Share by Country in 2019
Figure 93. Latin America Respiratory Drug Revenue Market Share by Country in 2019
Figure 94. Mexico Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Respiratory Drug Market Share by Type in 2019
Figure 101. Latin America Respiratory Drug Market Share by Application in 2019
Figure 102. Middle East and Africa Respiratory Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 103. Middle East and Africa Respiratory Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Respiratory Drug Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Respiratory Drug Revenue Market Share by Country in 2019
Figure 106. Turkey Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Turkey Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. Saudi Arabia Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Respiratory Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. U.A.E Respiratory Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Respiratory Drug Market Share by Type in 2019
Figure 113. Middle East and Africa Respiratory Drug Market Share by Application in 2019
Figure 114. North America Respiratory Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America Respiratory Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Respiratory Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe Respiratory Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Respiratory Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific Respiratory Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Respiratory Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America Respiratory Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Respiratory Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa Respiratory Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
肺/呼吸器ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 32810 million by 2026, from US$ 31560 million in 2020, at a CAGR of 3.7%% during 2021-2026. Global Pulmonary/ Respiratory Drug Delive…- 下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…
- 呼吸器疾患用吸入器の世界市場（～2026年） Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. …
- 呼吸ゲーティングシステムの世界市場（～2026年） Respiratory gating system is essential to the imaging diagnoses and the radiation therapy. The respiratory gating system is expected to grow over the forecast period owing to the increasing adoption of the products across the world. Market Analysis and Insights: Global Respiratory Gating System Mark…
- 気道感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Respiratory Tract Infection Treatment Market The global Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Respiratory Tract Infection Treatment S…